Cumberland Pharmaceuticals (CPIX) Enterprise Value (2016 - 2025)
Historic Enterprise Value for Cumberland Pharmaceuticals (CPIX) over the last 17 years, with Q3 2025 value amounting to -$15.5 million.
- Cumberland Pharmaceuticals' Enterprise Value rose 1270.67% to -$15.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$15.5 million, marking a year-over-year increase of 1270.67%. This contributed to the annual value of -$18.3 million for FY2024, which is 210.82% up from last year.
- Per Cumberland Pharmaceuticals' latest filing, its Enterprise Value stood at -$15.5 million for Q3 2025, which was up 1270.67% from -$16.4 million recorded in Q2 2025.
- Over the past 5 years, Cumberland Pharmaceuticals' Enterprise Value peaked at -$15.4 million during Q1 2025, and registered a low of -$27.3 million during Q4 2021.
- Over the past 5 years, Cumberland Pharmaceuticals' median Enterprise Value value was -$18.6 million (recorded in 2023), while the average stood at -$19.6 million.
- Per our database at Business Quant, Cumberland Pharmaceuticals' Enterprise Value surged by 3018.85% in 2022 and then crashed by 1287.61% in 2024.
- Cumberland Pharmaceuticals' Enterprise Value (Quarter) stood at -$27.3 million in 2021, then grew by 26.43% to -$20.1 million in 2022, then rose by 6.91% to -$18.7 million in 2023, then rose by 2.11% to -$18.3 million in 2024, then grew by 15.08% to -$15.5 million in 2025.
- Its Enterprise Value stands at -$15.5 million for Q3 2025, versus -$16.4 million for Q2 2025 and -$15.4 million for Q1 2025.